Synopsis
0
EU WC
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. A.m.k
2. Amikacin
3. Amikacina Medical
4. Amikacina Normon
5. Amikafur
6. Amikalem
7. Amikason's
8. Amikayect
9. Amikin
10. Amiklin
11. Amukin
12. Bb K 8
13. Bb K8
14. Bb-k 8
15. Bb-k8
16. Bbk 8
17. Bbk8
18. Biclin
19. Biklin
20. Gamikal
21. Kanbine
22. Medical, Amikacina
23. Normon, Amikacina
24. Oprad
25. Sulfate, Amikacin
26. Yectamid
1. Amikacin Disulfate
2. 39831-55-5
3. Pierami
4. Amikin
5. Amikacin Bis(sulphate)
6. Kaminax
7. Bb-k8
8. Arikayce
9. Amikacin Sulphate
10. Amikacin Disulphate
11. Amikacin (disulfate)
12. Amikacin (as Sulfate)
13. Amikacin Sulfate Salt
14. Amikacin Disulfate Salt
15. N6m33094fd
16. Nsc-755846
17. Amikafur
18. Amitrex
19. Biodacyn
20. Chemacin
21. Fabianol
22. Likacin
23. Biklin
24. Kancin-gap
25. Antibiotic Bb-k8 Sulfate
26. (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-2-(3-amino-3-deoxy-alpha-d-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-d-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide Disulfate
27. Amikacin (sulfate)
28. O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->4)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1->6))-n(3)-(4-amino-l-2-hydroxybutyryl)-2-deoxy-l-streptamine Sulfate (1:2)
29. Nn-k 8
30. Einecs 254-648-6
31. Amikan
32. Unii-n6m33094fd
33. Amikacini Sulfas
34. Amikacin Sulfate [usan:usp:jan]
35. Amikin (tn)
36. Amikin In Sodium Chloride 0.9% In Plastic Container
37. (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-2-[(2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2r,3r,4s,5s,6r)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]
38. Amikacin Sulfate In Sodium Chloride 0.9% In Plastic Container
39. Bay-416651 Sulfate
40. Amikacin Sulfate [mi]
41. Amikacin Sulfate [jan]
42. Amikacin Sulfate (jp17/usp)
43. Chebi:2638
44. Schembl1649432
45. Amikacin Sulfate [usan]
46. Amikacin Sulfate [vandf]
47. Chembl4208954
48. Hy-b0509b
49. Amikacin Sulfate [mart.]
50. Amikacin Sulfate [usp-rs]
51. Amikacin Sulfate [who-dd]
52. Amikacini Sulfas [who-ip]
53. Dtxsid601045247
54. Mfcd00167475
55. S3065
56. Amikacin Sulfate [green Book]
57. Akos025310105
58. Amikacin Sulfate [ep Impurity]
59. Amikacin Sulfate [orange Book]
60. Amikacin Sulfate [ep Monograph]
61. Ccg-270466
62. Cs-3493
63. Nsc 755846
64. Amikacin Sulfate [usp Monograph]
65. As-13777
66. D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1-4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)-, Sulfate (1:2)(salt)
67. O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-4)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1-6))-n(sup 3)-(4-amino-l-2-hydroxybutyryl)-2-deoxy-l-streptamine Sulfate (1:2)
68. D00865
69. 831a555
70. Q27105754
71. Amikacin Sulfate, European Pharmacopoeia (ep) Reference Standard
72. Amikacin Disulfate Salt, Potency: 674-786 Mug Per Mg (as Amikacin Base)
73. Amikacin Sulfate, United States Pharmacopeia (usp) Reference Standard
74. Amikacin For System Suitability, European Pharmacopoeia (ep) Reference Standard
75. Amikacin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
76. (2s)-4-amino-n-{(1r,2s,3s,4r,5s)-5-amino-2-[(3-amino-3-deoxy-alpha-d-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-d-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide Sulfate (1:2)
77. (s)-4-amino-n-((1r,2s,3s,4r,5s)-5-amino-2-(((2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4-(((2r,3r,4s,5s,6r)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide Bis(sulfate)
78. D-streptamine, O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)-, Sulfate (1:2) (salt)
79. D-streptamine, O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)-, Sulphate (1:2) (salt)
80. D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1.fwdarw.6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1.fwdarw.4))-n1-((2s)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, Sulfate (1:2) (salt)
81. O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->6))-n(sup 3)-(4-amino-l-2-hydroxybutyryl)-2-deoxy-l-streptamine Sulfate (1:2)
82. O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->6))-n(sup 3)-(4-amino-l-2-hydroxybutyryl)-2-deoxy-l-streptamine Sulphate (1:2)
Molecular Weight | 781.8 g/mol |
---|---|
Molecular Formula | C22H47N5O21S2 |
Hydrogen Bond Donor Count | 17 |
Hydrogen Bond Acceptor Count | 25 |
Rotatable Bond Count | 10 |
Exact Mass | 781.22049587 g/mol |
Monoisotopic Mass | 781.22049587 g/mol |
Topological Polar Surface Area | 498 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 900 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 16 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Amikacin sulfate |
Drug Label | Amikacin Sulfate Injection USP is a semi-synthetic aminoglycoside antibiotic derived from kanamycin. D-Streptamine,O-3-amino-3-deoxy--D-glucopyranosyl-(16)-O-[6-amino-6-deoxy--D-glucopyranosyl-(14)]-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy... |
Active Ingredient | Amikacin sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 250mg base/ml |
Market Status | Prescription |
Company | Emcure Pharms; Teva Pharms Usa; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Amikacin sulfate |
Drug Label | Amikacin Sulfate Injection USP is a semi-synthetic aminoglycoside antibiotic derived from kanamycin. D-Streptamine,O-3-amino-3-deoxy--D-glucopyranosyl-(16)-O-[6-amino-6-deoxy--D-glucopyranosyl-(14)]-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy... |
Active Ingredient | Amikacin sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 250mg base/ml |
Market Status | Prescription |
Company | Emcure Pharms; Teva Pharms Usa; Eurohlth Intl |
Treatment of nontuberculous mycobacterial lung infection, Treatment of Pseudomonas aeruginosa pulmonary infection / colonisation in patients with cystic fibrosis
Arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium Complex (MAC) in adults with limited treatment options who do not have cystic fibrosis.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01GB06
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-11-25
Pay. Date : 2013-11-18
DMF Number : 20874
Submission : 2007-09-18
Status : Active
Type : II
Registration Number : 222MF10057
Registrant's Address : No. 10678 Wenliang Road, Dongjia Town, Licheng District, Jinan, Shandong Province, P. R. CHINA
Initial Date of Registration : 2010-02-16
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-12-05
Pay. Date : 2013-07-05
DMF Number : 13763
Submission : 1998-09-01
Status : Active
Type : II
Registration Number : 301MF10052
Registrant's Address : Viale Addetta, 4/12, 20067 Tribiano (Milan) Italy
Initial Date of Registration : 2019-08-28
Latest Date of Registration : --
NDC Package Code : 52946-0600
Start Marketing Date : 2009-12-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13756
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13788
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21035
Submission : 2007-11-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22732
Submission : 2009-04-15
Status : Inactive
Type : II
NDC Package Code : 52946-0600
Start Marketing Date : 2009-12-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13722
Submission : 1998-09-01
Status : Inactive
Type : II
Certificate Number : R1-CEP 2010-308 - Rev 01
Issue Date : 2020-01-16
Type : Chemical
Substance Number : 1290
Status : Valid
Registrant Name : Korea Union Pharmaceutical Co., Ltd.
Registration Date : 2021-08-20
Registration Number : 20210625-210-J-1038(5)
Manufacturer Name : Shandong Anxin Pharmaceutical Co., Ltd
Manufacturer Address : No.849 Dongjia Town Licheng district, Jinan City, China
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?